China Adds CTD and DMF Filing Requirements to Enhance Drug Quality
This article was originally published in The Gold Sheet
Executive Summary
SHANGHAI – China’s State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China.